HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

poly(N- isopropylacrylamide- co- acrylamide- co- allylamine)

Also Known As:

PNIPAM-AAm-AA

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Dobashi, Toshiaki: 1 article (11/2008)
2.	Ma, Guanghui: 1 article (11/2008)
3.	Maki, Yasuyuki: 1 article (11/2008)
4.	Shen, Zheyu: 1 article (11/2008)
5.	Su, Zhiguo: 1 article (11/2008)
6.	Wan, Jinpei: 1 article (11/2008)
7.	Wei, Wei: 1 article (11/2008)
8.	Zhao, Yongjiang: 1 article (11/2008)

Related Diseases

1.

Neoplasms (Cancer)

11/15/2008 - "As expected, PAN can target cancer cells above the T(cp) of PNIPAM-AAm-AA, whereas it cannot below the T(cp). "
11/15/2008 - "PNIPAM-AAm-AA with different molecular weight (M(w)) was synthesized in the second step by radical polymerization and conjugated onto the surface of AN. Anti-cancer drug adriamycin (ADR) was then entrapped into the AN and PAN during the particle preparation. "
11/15/2008 - "Thermosensitive Poly(N-isopropylacrylamide-co-acrylamide-co-allylamine) (PNIPAM-AAm-AA)-conjugated albumin nanospheres (PAN) was developed as a new thermal targeting anti-cancer drug carrier by conjugating PNIPAM-AAm-AA on the surface of albumin nanospheres (AN). "

Related Drugs and Biologics

1.	poly(N- isopropylacrylamide- co- acrylamide- co- allylamine)
2.	Drug Carriers
3.	Doxorubicin (Adriamycin)
4.	Albumins

Related Therapies and Procedures

1.	Nanospheres